Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global...(fact constitute forward-looking stateme...)

Date:9/25/2008

fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In particular, readers are cautioned that outlooks and projections of future results presented in this press release should be considered uncertain and forward-looking. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.

'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Copyright©2008 PR Newswire. All rights reserved

4 GOOD

Page: 1 2 3 4
Related biology technology :

1. Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
2. Neptune Technologies decided not to re-price options
3. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
4. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
5. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
6. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
7. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
8. Neptune Technologies expands into medicinal markets in Asia Pacific
9. Neptune Technologies receives GRAS notification in the United States
10. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
11. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States